Articles

Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason. More

Penny stock investing is a fool's errand but never say never as there are still a few undervalued penny stocks to buy. More

HTHIY stock results show that Hitachi beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. More

Suntory Beverage & Food just reported results for the first quarter of 2024. More

SPEC stock results show that Spectaire Holdings missed analyst estimates for earnings per share the first quarter of 2024. More

Pieris Pharmaceuticals just reported results for the first quarter of 2024. More

GlucoTrack just reported results for the first quarter of 2024. More

Subscriber Sign in